Nu-Med Plus (NUMD) Total Current Liabilities (2011 - 2025)

Nu-Med Plus has disclosed Total Current Liabilities across 15 years of filings, most recently posting $279189.0 for Q4 2025.

• Total Current Liabilities for Q4 2025 came in at $279189.0, up 24.38% year-over-year; the trailing twelve-month figure through Dec 2025 was $279189.0 (up 24.38% YoY), and the FY2025 annual result was $279189.0, up 24.38% from the prior year.
• Total Current Liabilities came in at $279189.0 for Q4 2025 at Nu-Med Plus, up from $263708.0 in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $279189.0 in Q4 2025 to a low of $84674.0 in Q1 2021.
• The 5-year median for Total Current Liabilities is $187249.0 (2024), against an average of $188808.2.
• Across the five-year window, Total Current Liabilities tumbled 79.57% in 2021 and jumped 181.47% in 2022, its largest moves.
• Nu-Med Plus' Total Current Liabilities stood at $154521.0 in 2021, then slipped by 7.73% to $142570.0 in 2022, then gained by 12.37% to $160207.0 in 2023, then surged by 40.11% to $224469.0 in 2024, then grew by 24.38% to $279189.0 in 2025.
• The last three Total Current Liabilities figures came in at $279189.0 (Q4 2025), $263708.0 (Q3 2025), and $254857.0 (Q2 2025), per Business Quant data.